Yumanity Therapeutics Funding: $47M Raised, Series A (2021)
Yumanity Therapeutics is based in Seattle, WA. It has raised $47M in total funding. Latest round: Series A.
Yumanity Therapeutics funding overview
Yumanity Therapeutics is based in Seattle, WA. Yumanity Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Yumanity Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Fidelity Investments, Redmile Group, Sanofi, Biogen, Alexandria Venture Investments, Dolby Family Ventures. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Yumanity Therapeutics funding
How much has Yumanity Therapeutics raised?
Yumanity Therapeutics has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Yumanity Therapeutics?
Fidelity Investments, Redmile Group, Sanofi, Biogen, Alexandria Venture Investments, Dolby Family Ventures are named among the investors backing Yumanity Therapeutics.
What was the latest Yumanity Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Yumanity Therapeutics based?
Yumanity Therapeutics is based in Seattle, WA.
When did Yumanity Therapeutics last raise?
The last disclosed Yumanity Therapeutics round closed in January 2021 at Series A.
Round data for Yumanity Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Seattle and backer lists below.
